New Version of CRISPR Corrects RNA Defects Linked to Huntington’s, ALS

News   Aug 15, 2017 | Original story from University of California, San Diego

 
New Version of CRISPR Corrects RNA Defects Linked to Huntington’s, ALS

These are muscle cells from a patient with myotonic dystrophy type I, untreated (left) and treated with the RNA-targeting Cas9 system (right). The MBNL1 protein is in green, repetitive RNA in red and the cell’s nucleus in blue. MBNL1 is an important RNA-binding protein and its normal function is disrupted when it binds repetitive RNA. In the treated cells on the right, MBNL1 is released from the repetitive RNA. Credit: UCSD

 
 
 

RELATED ARTICLES

Absence Epilepsy Seizures Visualized in the Brain

News

Researchers took a closer look at the firing activity of neurons in an area of the visual cortex of a genetic mouse model of absence epilepsy.

READ MORE

Protein Turnover Rates Differ Across the Brain

News

Scientists have revealed that protein molecules in the brain are broken down and replaced at different rates, depending on where in the brain they are.

READ MORE

Glial-Neuronal Interaction Fundamental for Memory

News

When astrocytes in mice overproduce a protein called ephrin-B1, the ability of the animal to retain memory weakens.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Genomics Research Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy